Double-Cycle, High-Dose Ifosfamide, Carboplatin, and Etoposide Followed by Peripheral Blood Stem-Cell Transplantation for Small Cell Lung Cancer

Article ID	Journal	Published Year	Pages	File Type
2907109	Chest	2005	6 Pages	PDF

Abstract

Double-cycle, high-dose ICE therapy followed by PBSCT is tolerable and feasible even after conventional chemotherapy or chemoradiotherapy in patients with SCLC.

Keywords

NCR PBSCT PBSC ABMT SCLC Limited disease Extensive disease Small cell lung cancer Peripheral blood stem cell High-dose chemotherapy granulocyte colony-stimulating factor G-CSF Partial response complete response Autologous bone marrow transplantation Ice

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Preview

Double-Cycle, High-Dose Ifosfamide, Carboplatin, and Etoposide Followed by Peripheral Blood Stem-Cell Transplantation for Small Cell Lung Cancer

Authors

Iwasaki MD, PhD, Nagata MD, Nakanishi MD, Natuhara MD, Kubota MD, Ueda MD, Arimoto MD, PhD, Hara MD, PhD,